The stock of Emcure Pharmaceuticals has been in a long-term uptrend. After hitting a high of ₹2,047.40 on August 10, the price dropped. Nevertheless, the broader rally is intact as key support levels stay valid. Notable support levels are ₹1,850 and ₹1,780. As long as these levels hold, the outlook will be positive. Therefore, we expect the stock to resume the rally either from the current level of ₹1,871 or after a decline to ₹1,780.Video Credit: BusinesslineBefore the end of this year, the scrip can appreciate to ₹2,100. So, go long at ₹1,871 and accumulate at ₹1,800. Place stop-loss at ₹1,720. When the stock rallies to ₹2,000 and ₹2,050, alter the stop-loss to ₹1,925 and ₹2,000 respectively. Book profits at ₹2,100.(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)Published on August 31, 2026